Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Federal prosecutors indict former baseball player Doug DeCinces and 3 others on insider trading charges stemming from Abbott’s 2009 acquisition of Advanced Medical Optics.
The FDA touts the success of its 36-point "Plan of Action" for streamlining the medical device premarket review process, noting improvements in predictability in transparency for the 1st time in nearly a decade.
Venture capitalists spend more money on lifesciences deals during the 3rd quarter of 2012, but the medical device segment hits hard times as biotech takes the fore, according to a PricewaterhouseCoopers U.S. report.